Women Board Cancer Treatment entered the industry of Internal Medicine Doctors in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 6211110, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact Theresa Stark by calling (312) 942-5751 during business hours. You can also write to the business’ Single Location at 500 South Paulina St, Chicago, Illinois IL 60612. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Women Board Cancer Treatment |
| Representative: | Theresa Stark |
| Place of Business: | 500 South Paulina St, Chicago, IL 60612 |
| Contact Number: | (312) 942-5751 |
| Type of Service: | Internal Medicine Doctors |
| SIC Number: | 8011 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2002 |
| Income/Year: | $2.500.000 to $4.999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Women Board Cancer Treatment is a company operating from Cook, Illinois providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2002 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 6211110 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Women Board Cancer Treatment has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative Theresa Stark at (312) 942-5751 for related queries, or to locate its Single Location using the coordinates 41.87541,-87.66926.
The Single Location can also be found at the street address 500 South Paulina St in Chicago, Illinois 60612 and can be engaged online through the company website at , the company Twitter , and Facebook page .